Clinical Trials for Cumberland Pharmaceuticals

Explore 5 clinical trials worldwide

Showing 1-5 of 5 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cumberland Pharmaceuticals

Clinical Trials (5)

NCT06119061
Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With Subarachnoid Hemorrhage
PHASE4Recruiting
20 participants
Started: Jul 2, 2024 · Completed: Jan 31, 2026
1 condition2 sponsors1 location
NCT05571059
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
PHASE2Recruiting
128 participants
Started: Jan 31, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor17 locations
NCT03340675
Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
PHASE2Active, not recruiting
48 participants
Started: Oct 19, 2020 · Completed: Dec 31, 2025
2 conditions2 sponsors10 locations
NCT03694249
Ifetroban in Treating Patients With Malignant Solid Tumors at High Risk of Metastatic Recurrence
PHASE2Active, not recruiting
30 participants
Started: Dec 12, 2018 · Completed: Apr 30, 2026
1 condition2 sponsors1 location
NCT02682511
Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
PHASE2Active, not recruiting
34 participants
Started: Jan 31, 2017 · Completed: May 31, 2026
8 conditions1 sponsor13 locations